Dilution of Existing Shareholders Through Exercise of Stock Acquisition Rights
First written in FY2020. 11 of 13 entries say "Materialised", first in FY2021-Q1. Latest entry: 2026-08-12.
Landix moved to the "Worse" side of this theme in 2020, the same year as the typical company in this theme.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
69 other companies' latest entry also says "Materialised".
- 2026-08-12MaterialisedEarnings
「First quarter of the fiscal year ending March 2027 5,699,586 shares」
Shares issued at period-end increased from 5,695,586 at the end of the previous consolidated fiscal year to 5,699,586, indicating continued dilution through share issuance. - FY2026MaterialisedAnnual report
「1 July 2025–31 March 2026” “Increase from the exercise of stock acquisition rights (stock options)” “As of the end of the consolidated fiscal year under review, the number of potential shares from stock acquisition rights was 42,000, equivalent to 0.7% of the total 5,695,586 shares issued.」
During the year, 26,000 shares were issued through the exercise of stock acquisition rights, and dilution continued to materialize as actual share issuance. At year-end, potential shares totaled 42,000, equivalent to 0.7% of total shares issued. - 2026-05-12MaterialisedEarnings
「Issuance of new shares (exercise of share acquisition rights)」
During the consolidated fiscal year, stated capital and capital surplus each increased by ¥7,280 thousand, while the number of shares issued at period-end increased by 26,000 from the end of the previous fiscal year. Dilution from the exercise of share acquisition rights progressed through the actual issuance of shares. - FY2025MaterialisedAnnual report
「1 April 2024–31 March 2025” “Increase from the exercise of stock acquisition rights (stock options)” “As of the end of the consolidated fiscal year under review, the number of potential shares from stock acquisition rights was 34,000, equivalent to 1.20% of the total 2,834,793 shares issued.」
During the year, 2,000 shares were issued through the exercise of stock acquisition rights, and dilution continued to materialize as actual share issuance. At year-end, potential shares totaled 34,000, equivalent to 1.20% of total shares issued, down from 36,000 shares, or 1.27%, in the previous year. - FY2024MaterialisedAnnual report
「Increase of 5,000 shares from the issuance of new shares through the exercise of stock acquisition rights」
During the fiscal year, 5,000 shares were issued through the exercise of stock acquisition rights. At year-end, potential shares totaled 36,000, equivalent to 1.27% of total shares issued, and dilution progressed in practice through actual share issuance. - FY2024-Q2MaterialisedAnnual report
「Between 1 October and 31 October 2023, the exercise of stock acquisition rights increased total shares issued by 5,000 and increased stated capital and capital reserves by ¥2.800 million each.」
After the quarter-end, 5,000 shares were issued through the exercise of stock acquisition rights, and dilution from potential shares continued to materialize as actual share issuance. - FY2023MitigatedAnnual report
「As of the end of the consolidated fiscal year under review, the number of potential shares from stock acquisition rights was 41,000, equivalent to 1.45% of the total 2,827,793 shares issued.」
No shares were issued through the exercise of stock acquisition rights during the year, and potential shares decreased from 58,100, or 2.06%, in the previous year to 41,000, or 1.45%. The dilution risk narrowed numerically. - FY2022-Q2MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
Between July and September 2021, the number of shares increased by 3,500 through the exercise of stock acquisition rights, bringing total shares issued to 2,827,793 as of 30 September 2021. The dilution risk continued to materialize as actual share issuance. - FY2021MaterialisedAnnual report
「1 April 2020–31 March 2021” “Increase from the exercise of stock acquisition rights (stock options)” “As of the end of the consolidated fiscal year under review, the number of potential shares from stock acquisition rights was 58,100, equivalent to 2.06% of the total 2,824,293 shares issued.」
During the year, 48,900 shares were issued through the exercise of stock acquisition rights, and dilution progressed in practice. At year-end, potential shares totaled 58,100, equivalent to 2.06% of total shares issued. - FY2021-Q3MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
Between October and December 2020, the number of shares increased by 6,500 through the exercise of stock acquisition rights, bringing total shares issued to 2,809,593 as of 31 December 2020. The dilution risk continued to materialize as actual share issuance during the period. - FY2021-Q2MaterialisedAnnual report
「Proceeds from issuance of shares 31,024」
Proceeds from the issuance of shares of ¥31.024 million were recorded during the cumulative second-quarter period, and total shares issued as of 30 September 2020 were 2,803,093. This filing does not explicitly state that the issuance resulted from the exercise of stock acquisition rights. - FY2021-Q1MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
Between 1 April and 30 June 2020, the number of shares increased by 27,700 through the exercise of stock acquisition rights, and the dilution risk from potential shares materialized as actual share issuance. - FY2020First statedAnnual report
「As of the end of the consolidated fiscal year under review, the number of potential shares from stock acquisition rights was 112,300, equivalent to 4.05% of the total 2,775,393 shares issued.」
The dilution risk from the exercise of stock options was quantitatively disclosed as 112,300 potential shares, equivalent to 4.05% of total shares issued.